2.615USD-2.43%Mkt Cap: 488.06M USDP/E: —Last update: 2026-06-01
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The co…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap488.06M USD
Enterprise Value367.08M USD
Revenue (TTM)7.12M USD
Gross Profit7.12M USD
Net Income (TTM)-17.41M USD
Revenue/Share0.0790 USD
Last Price2.615 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees23
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6904691010
Valuation
P/E (Trailing)—
P/E (Forward)-6.04
PEG—
EV/EBITDA-7.72
EV/Revenue51.54
P/S71.54
P/B2.72
EPS (TTM)-0.21
EPS (Forward)-0.45
52W Range
0.270083% of range3.105
52W High3.105 USD
52W Low0.2700 USD
Profitability
Gross Margin100.00%
Oper. Margin-670.25%
EBITDA Margin0.00%
Profit Margin-240.13%
ROE-13.33%
ROA-11.54%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-38.33M USD
CapEx (TTM)—
FCF Margin-283.86%
FCF Yield-4.14%
Net Debt-142.45M USD
Net Debt/EBITDA2.99
Balance Sheet
Debt/Equity0.10
Current Ratio10.17
Quick Ratio9.88
Book Value/Sh1.004 USD
Cash/Share0.8330 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)5.471 USD
Target Range4.000 USD – 7.000 USD
# Analysts9
Ownership
Shares Out.186.64M
Float161.29M
Insiders6.98%
Institutions61.57%
Short Interest
Short Ratio4.7d
Short % Float6.23%
Short % Out.5.41%
Shares Short10.09M
Short (prev mo.)6.96M
Technical
SMA 502.607 (+0.3%)
SMA 2001.778 (+47.1%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)1.72M
Avg Vol (10d)1.24M
Technical Indicators
RSI (14)54.0
MACD-0.0226
MACD Signal-0.0133
MACD Hist.-0.0093
BB Upper3.019 USD
BB Middle2.657 USD
BB Lower2.296 USD
BB Width27.21%
ATR (14)0.1670 USD
Vol Ratio (20d)0.70x